• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国心脏瓣膜病患者行心脏手术的临床特征、结局和区域性差异。

Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China.

机构信息

Cardiac Surgery Centre, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167, North Lishi Street, Xicheng District, , Beijing, 100037, China.

出版信息

BMC Cardiovasc Disord. 2022 Apr 21;22(1):188. doi: 10.1186/s12872-022-02612-x.

DOI:10.1186/s12872-022-02612-x
PMID:35448947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9026662/
Abstract

AIMS

To characterize surgical valvular heart diseases (VHDs) in China and disclose regional variations in VHD surgeries by analyzing the data derived from the Chinese Cardiac Surgery Registry (CCSR).

METHODS AND RESULTS

From January 2016 to December 2018, we consecutively collected the demographic information, clinical characteristics and outcomes of 38,131 adult patients undergoing valvular surgery in China. We sought to assess the quality of VHD surgery by examining in-hospital deaths of all patients from 7 geographic regions. Using a hierarchical generalized linear model, we calculated the risk-standardized mortality rate (RSMR) of each region. By comparing VHD characteristics and RSMRs, we pursued an investigation into regional variations. The mean age was 54.4 ± 12.4 years, and 47.2% of the patients were females. Among cases, the number of aortic valve surgeries was 9361 (24.5%), which was less than that of mitral valve surgeries (n = 14,506, 38.0%). The number of concurrent aortic and mitral valve surgeries was 6984 (18.3%). A total of 4529 surgical VHD patients (11.9%) also underwent coronary artery bypass grafting (CABG) surgery. The overall in-hospital mortality rate was 2.17%. The lowest RSMR, 0.91%, was found in the southwest region, and the highest RSMR, 3.99%, was found in the northeast.

CONCLUSION

Although the overall valvular surgical mortality rate in large Chinese cardiac centers was in line with high-income countries, there were marked regional variations in the characteristics and outcomes of surgical VHD patients across China.

摘要

目的

通过分析中国心脏手术注册(CCSR)的数据,描述中国的外科心脏瓣膜病(VHD)特征,并揭示 VHD 手术的地区差异。

方法和结果

2016 年 1 月至 2018 年 12 月,我们连续收集了中国 38131 例成年 VHD 手术患者的人口统计学信息、临床特征和结局。我们试图通过检查来自 7 个地理区域的所有患者的住院内死亡情况来评估 VHD 手术的质量。使用分层广义线性模型,我们计算了每个地区的风险标准化死亡率(RSMR)。通过比较 VHD 特征和 RSMR,我们调查了地区差异。患者的平均年龄为 54.4±12.4 岁,其中 47.2%为女性。在这些病例中,主动脉瓣手术数量为 9361 例(24.5%),低于二尖瓣手术(n=14506 例,38.0%)。同期行主动脉瓣和二尖瓣手术的患者有 6984 例(18.3%)。共有 4529 例外科 VHD 患者(11.9%)还接受了冠状动脉旁路移植术(CABG)。总体住院死亡率为 2.17%。西南地区的 RSMR 最低,为 0.91%,东北地区的 RSMR 最高,为 3.99%。

结论

尽管中国大型心脏中心的整体瓣膜手术死亡率与高收入国家相当,但中国外科 VHD 患者的特征和结局在各地区存在明显差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/b102254617de/12872_2022_2612_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/591f7a3e37d6/12872_2022_2612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/fa665ed94865/12872_2022_2612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/c0670daaadf8/12872_2022_2612_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/b102254617de/12872_2022_2612_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/591f7a3e37d6/12872_2022_2612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/fa665ed94865/12872_2022_2612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/c0670daaadf8/12872_2022_2612_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3262/9026662/b102254617de/12872_2022_2612_Fig4_HTML.jpg

相似文献

1
Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China.中国心脏瓣膜病患者行心脏手术的临床特征、结局和区域性差异。
BMC Cardiovasc Disord. 2022 Apr 21;22(1):188. doi: 10.1186/s12872-022-02612-x.
2
Coronary artery bypass graft: contemporary heart surgery center performance in China.冠状动脉搭桥术:中国当代心脏外科中心的表现
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):214-21. doi: 10.1161/CIRCOUTCOMES.111.962365. Epub 2012 Mar 6.
3
Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States.美国医院容量在识别低绩效和高绩效主动脉瓣及二尖瓣手术中心中的作用。
JAMA Cardiol. 2017 Dec 1;2(12):1322-1331. doi: 10.1001/jamacardio.2017.4003.
4
Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.《日本心房颤动患者瓣膜性心脏病对死亡率、血栓栓塞和心脏事件的影响 - 伏见心房颤动登记研究》。
Circ J. 2020 Apr 24;84(5):714-722. doi: 10.1253/circj.CJ-19-1158. Epub 2020 Mar 25.
5
The Turkish registry of heart valve disease.土耳其心脏瓣膜病登记处。
Turk Kardiyol Dern Ars. 2013 Jan;41(1):1-10. doi: 10.5543/tkda.2013.71430.
6
Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.在经导管主动脉瓣置换术时代之前,瓣膜性心脏病的进展缓慢:在过去的三十年中,死亡率不断上升,而死亡率的变化极小。
Am Heart J. 2014 Apr;167(4):562-567.e2. doi: 10.1016/j.ahj.2013.12.030. Epub 2014 Jan 14.
7
Coronary artery disease in patients undergoing cardiac surgery for non-coronary lesions in a tertiary care centre.在一家三级医疗中心,接受非冠状动脉病变心脏手术患者的冠状动脉疾病
Indian Heart J. 2014 Jan-Feb;66(1):52-6. doi: 10.1016/j.ihj.2013.12.014. Epub 2013 Dec 28.
8
Baseline and Outcome Characteristics of Multiple Valve Surgery Compared with Single Valve Procedures in Mainland China: A Multicenter Experience.中国大陆多瓣膜手术与单瓣膜手术的基线和结局特征:一项多中心经验
Heart Surg Forum. 2019 Dec 17;22(6):E486-E493. doi: 10.1532/hsf.2369.
9
Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients.心脏瓣膜手术和厌食症药物摄入史:对大样本苯氟雷司暴露患者的回顾性研究。
Arch Cardiovasc Dis. 2022 Jun-Jul;115(6-7):348-358. doi: 10.1016/j.acvd.2022.03.006. Epub 2022 May 14.
10
Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.多瓣膜心脏疾病患者的特征、治疗和结局:EURObservational Research Programme Valvular Heart Disease II 调查的一项子研究。
Eur Heart J. 2022 Aug 1;43(29):2756-2766. doi: 10.1093/eurheartj/ehac209.

引用本文的文献

1
A Three-Day Prehabilitation Program is Cost-Effective for Preventing Pulmonary Complications after Heart Valve Surgery: A Health Economic Analysis of a Randomized Trial.一项为期三天的术前康复计划在预防心脏瓣膜手术后肺部并发症方面具有成本效益:一项随机试验的卫生经济学分析。
Rev Cardiovasc Med. 2024 Sep 10;25(9):323. doi: 10.31083/j.rcm2509323. eCollection 2024 Sep.
2
A New Risk Score for Predicting Postoperative Mortality in Suspected Heart Failure Patients Undergoing Valvular Surgery.一种用于预测接受瓣膜手术的疑似心力衰竭患者术后死亡率的新风险评分。
Rev Cardiovasc Med. 2023 Feb 2;24(2):38. doi: 10.31083/j.rcm2402038. eCollection 2023 Feb.
3

本文引用的文献

1
European Society of Cardiology: cardiovascular disease statistics 2021.欧洲心脏病学会:2021年心血管疾病统计数据
Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892.
2
Persisting burden and challenges of rheumatic heart disease.风湿性心脏病的持续负担和挑战。
Eur Heart J. 2021 Sep 7;42(34):3338-3348. doi: 10.1093/eurheartj/ehab407.
3
Global epidemiology of valvular heart disease.全球瓣膜性心脏病的流行病学。
Transcatheter aortic valve replacement in China - a review of the available evidence.
中国经导管主动脉瓣置换术——现有证据综述
AsiaIntervention. 2024 Jul 26;10(2):110-118. doi: 10.4244/AIJ-D-23-00049. eCollection 2024 Jul.
4
Protocol for the PORT study: short-term perioperative rehabilitation to improve outcomes in cardiac valvular surgery - a randomised control trial.PORT 研究方案:心脏瓣膜手术围手术期短期康复以改善结局——一项随机对照试验。
BMJ Open. 2023 Dec 21;13(12):e074837. doi: 10.1136/bmjopen-2023-074837.
Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25.
4
Survival of people with valvular heart disease in a large, English community-based cohort study.基于大型、英国社区的队列研究,瓣膜性心脏病患者的生存情况。
Heart. 2021 Aug;107(16):1336-1343. doi: 10.1136/heartjnl-2020-318823. Epub 2021 May 24.
5
STS Adult Cardiac Surgery Database: 2021 Update on Outcomes, Quality, and Research.STS 成人心脏外科学数据库:2021 年手术结果、质量和研究更新。
Ann Thorac Surg. 2021 Jun;111(6):1770-1780. doi: 10.1016/j.athoracsur.2021.03.043. Epub 2021 Mar 29.
6
Dismal Outcomes and High Societal Burden of Mitral Valve Regurgitation in France in the Recent Era: A Nationwide Perspective.法国近期二尖瓣反流的不良结局和高社会负担:全国视角。
J Am Heart Assoc. 2020 Aug 4;9(15):e016086. doi: 10.1161/JAHA.120.016086. Epub 2020 Jul 22.
7
Distressed communities are associated with worse outcomes after coronary artery bypass surgery.在冠状动脉旁路手术后,处于困境中的社区与更差的结果相关。
J Thorac Cardiovasc Surg. 2020 Aug;160(2):425-432.e9. doi: 10.1016/j.jtcvs.2019.06.104. Epub 2019 Aug 22.
8
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.当代瓣膜性心脏病的表现与处理:EURObservational Research Programme-Valvular Heart Disease II 调查。
Circulation. 2019 Oct;140(14):1156-1169. doi: 10.1161/CIRCULATIONAHA.119.041080. Epub 2019 Sep 12.
9
Global cardiac surgery: Access to cardiac surgical care around the world.全球心脏外科学:世界各地的心脏外科学术治疗途径。
J Thorac Cardiovasc Surg. 2020 Mar;159(3):987-996.e6. doi: 10.1016/j.jtcvs.2019.04.039. Epub 2019 Apr 26.
10
Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study.中国心血管疾病负担,1990-2016 年:来自 2016 年全球疾病负担研究的发现。
JAMA Cardiol. 2019 Apr 1;4(4):342-352. doi: 10.1001/jamacardio.2019.0295.